Climb Bio, Inc. Quarterly Operating Income (Loss) in USD from Q2 2020 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Climb Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q3 2024.
- Climb Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$11.7M, a 135% decline year-over-year.
- Climb Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$76.2M, a 70.5% decline year-over-year.
- Climb Bio, Inc. annual Operating Income (Loss) for 2023 was -$40.3M, a 10.8% increase from 2022.
- Climb Bio, Inc. annual Operating Income (Loss) for 2022 was -$45.1M, a 26.5% decline from 2021.
- Climb Bio, Inc. annual Operating Income (Loss) for 2021 was -$35.7M, a 70.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)